![Brittany Brown](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brittany Brown
Direktor/Vorstandsmitglied bei Stem Cell Bra
Aktive Positionen von Brittany Brown
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Stem Cell Bra
![]() Stem Cell Bra Apparel/FootwearConsumer Non-Durables Stem Cell Bra is an American company that is currently in the pre-clinical testing stage of developing a bra that uses stem cells from a woman's own fat tissue and bone marrow to possibly increase breast size by one cup over a period of 12 weeks. The stem cell bra has shown promising results in a pilot feasibility clinical study conducted in Spain in 2021, with 1/3 of the enrollees experiencing a one cup size increase, 1/3 experiencing a 10% increase, and 1/3 experiencing no change. The company has gathered safety data on 15 sheep and cows with excellent results, showing an increase in breast fullness volume ranging from 20 to 30% and true new breast tissue formation. The company has over 150 USPTO patent and patent pending claims on bioelectric regeneration methods and devices. However, the company cautions that the product is only available in countries where clinical studies have been approved by regulatory authorities and is not yet proven safe or effective in statistically significant controlled clinical studies. The company was founded by Howard J. Leonhardt, who has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - | - |
LGS Foundation, Inc. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Brittany Brown
Ehemalige bekannte Positionen von Brittany Brown
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Second Heart Assist, Inc.
![]() Second Heart Assist, Inc. Medical SpecialtiesHealth Technology Second Heart Assist, Inc. develops minimally invasive circulatory support platform based on proprietary aortic stent pump technology. The firm's product will be a catheter-based temporary assist pump to treat patients with acute decompensated heart failure and to provide circulatory support to those undergoing percutaneous coronary intervention (PCI). The company was founded by Leslie Miller, Howard J. Leonhardt and Jeff Donofrio in 2015 and is headquartered in Santa Monica, CA. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Director/Board Member | 3 |
Sektoral
Health Technology | 2 |
Consumer Non-Durables | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Second Heart Assist, Inc.
![]() Second Heart Assist, Inc. Medical SpecialtiesHealth Technology Second Heart Assist, Inc. develops minimally invasive circulatory support platform based on proprietary aortic stent pump technology. The firm's product will be a catheter-based temporary assist pump to treat patients with acute decompensated heart failure and to provide circulatory support to those undergoing percutaneous coronary intervention (PCI). The company was founded by Leslie Miller, Howard J. Leonhardt and Jeff Donofrio in 2015 and is headquartered in Santa Monica, CA. | Health Technology |
Stem Cell Bra
![]() Stem Cell Bra Apparel/FootwearConsumer Non-Durables Stem Cell Bra is an American company that is currently in the pre-clinical testing stage of developing a bra that uses stem cells from a woman's own fat tissue and bone marrow to possibly increase breast size by one cup over a period of 12 weeks. The stem cell bra has shown promising results in a pilot feasibility clinical study conducted in Spain in 2021, with 1/3 of the enrollees experiencing a one cup size increase, 1/3 experiencing a 10% increase, and 1/3 experiencing no change. The company has gathered safety data on 15 sheep and cows with excellent results, showing an increase in breast fullness volume ranging from 20 to 30% and true new breast tissue formation. The company has over 150 USPTO patent and patent pending claims on bioelectric regeneration methods and devices. However, the company cautions that the product is only available in countries where clinical studies have been approved by regulatory authorities and is not yet proven safe or effective in statistically significant controlled clinical studies. The company was founded by Howard J. Leonhardt, who has been the CEO since incorporation. | Consumer Non-Durables |
LGS Foundation, Inc. |
- Börse
- Insiders
- Brittany Brown
- Erfahrung